DCGI permits Bharat Biotech to conduct trials for intranasal booster dose

28-01-2022 Fri 18:37 IST | IANS | Health
DCGI permits Bharat Biotech to conduct trials for intranasal booster dose

New Delhi, Jan 28:  In a major development on Friday, the Drugs Controller General of India (DCGI) allowed Hyderabad-based vaccine manufacturer Bharat Biotech to conduct clinical trials for its intranasal Covid booster dose in India.

The clinical trials will be conducted at nine different sites, including AIIMS Delhi.

The vaccine manufacturer had proposed the booster dose for those who have been already been inoculated with Covishield and Covaxin vaccines.

"Granting permission to conduct clinical trials with vaccine does not convey or imply that, based on the clinical trial data generated with the vaccine, permission to market this vaccine in the country will automatically be granted," said the national drugs regulator.

Bharat Biotech plans to conduct clinical trials on both who have taken Covishield or Covaxin vaccine shots. As per sources, the trials will be conducted on half individuals who have received Covishield and another half who have been administered Covaxin.

A gap of around six months is expected between the second vaccine shot and the intranasal booster dose.

The intranasal vaccine reportedly has the potential to prevent transmission of new Covid variants. 


More News
Andhra kept Covid mortality rate at lowest despite handicaps: Jagan
8 minutes ago
TRS leaders slam TPCC chief Revanth’s comments on castes
20 minutes ago
Modi participates in event to launch Indo-Pacific Economic Framework for Prosperity
58 minutes ago
Kriti Sanon turns entrepreneur as she completes eight years in Bollywood
1 hour ago
IPL 2022: Debutants Titans face off against Rajasthan Royals in direct ticket to final
1 hour ago
Rolls-Royce India President Kishore Jayaraman receives honorary British award
1 hour ago
Now get PAN card, driving licence via MyGov Helpdesk on WhatsApp
1 hour ago
Harish Rao makes surprise visit to Kondapur Area Hospital, suspends doctor
1 hour ago
Modi meets industry leaders in Japan, invites them to invest in India
2 hours ago
Naga Chaitanya discovers the best way to commemorate 'Manam' journey
2 hours ago
Chandrababu demands Jagan govt to slash taxes on fuel
2 hours ago
K'taka Cong MLA eats food removed from Dalit seer's mouth, video goes viral
2 hours ago
Class 10 exams begin in Telangana after 2-yr Covid gap
3 hours ago
Andhra joins WEF's global network of advanced manufacturing hubs
4 hours ago
Adivi Sesh's pan-India film 'Major' getting ready for nationwide previews
4 hours ago
Infosys reappoints Salil Parekh as CEO and MD
4 hours ago
I'm not running your Twitter account, Musk tells Pune techie
4 hours ago
NBK108: Anil Ravipudi reveals Sreeleela will play Balakrishna's daughter
4 hours ago
First schedule of Samantha-Vijay Deverakonda starrer 'Kushi' wraps up
4 hours ago
Global Covid caseload tops 525.5 mn
6 hours ago